571 related articles for article (PubMed ID: 17257456)
1. Cefdinir vs. cephalexin for mild to moderate uncomplicated skin and skin structure infections in adolescents and adults.
Giordano PA; Elston D; Akinlade BK; Weber K; Notario GF; Busman TA; Cifaldi M; Nilius AM
Curr Med Res Opin; 2006 Dec; 22(12):2419-28. PubMed ID: 17257456
[TBL] [Abstract][Full Text] [Related]
2. Efficacy, tolerability, and parent reported outcomes for cefdinir vs. high-dose amoxicillin/clavulanate oral suspension for acute otitis media in young children.
Block SL; Schmier JK; Notario GF; Akinlade BK; Busman TA; Mackinnon GE; Halpern MT; Nilius AM
Curr Med Res Opin; 2006 Sep; 22(9):1839-47. PubMed ID: 16968587
[TBL] [Abstract][Full Text] [Related]
3. Cefdinir versus levofloxacin in patients with acute rhinosinusitis of presumed bacterial etiology: a multicenter, randomized, double-blind study.
Henry DC; Kapral D; Busman TA; Paris MM
Clin Ther; 2004 Dec; 26(12):2026-33. PubMed ID: 15823766
[TBL] [Abstract][Full Text] [Related]
4. A comparison of 5 days of therapy with cefdinir or azithromycin in children with acute otitis media: a multicenter, prospective, single-blind study.
Block SL; Cifaldi M; Gu Y; Paris MM
Clin Ther; 2005 Jun; 27(6):786-94. PubMed ID: 16117986
[TBL] [Abstract][Full Text] [Related]
5. Randomized, double-blind comparison of once-weekly dalbavancin versus twice-daily linezolid therapy for the treatment of complicated skin and skin structure infections.
Jauregui LE; Babazadeh S; Seltzer E; Goldberg L; Krievins D; Frederick M; Krause D; Satilovs I; Endzinas Z; Breaux J; O'Riordan W
Clin Infect Dis; 2005 Nov; 41(10):1407-15. PubMed ID: 16231250
[TBL] [Abstract][Full Text] [Related]
6. Cefdinir versus cephalexin for the treatment of skin and skin-structure infections. The Cefdinir Adult Skin Infection Study Group.
Tack KJ; Littlejohn TW; Mailloux G; Wolf MM; Keyserling CH
Clin Ther; 1998; 20(2):244-56. PubMed ID: 9589816
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study.
Lucasti C; Jasovich A; Umeh O; Jiang J; Kaniga K; Friedland I
Clin Ther; 2008 May; 30(5):868-83. PubMed ID: 18555934
[TBL] [Abstract][Full Text] [Related]
8. Moxifloxacin versus cephalexin in the treatment of uncomplicated skin infections.
Parish LC; Routh HB; Miskin B; Fidelholtz J; Werschler P; Heyd A; Haverstock D; Church D
Int J Clin Pract; 2000 Oct; 54(8):497-503. PubMed ID: 11198726
[TBL] [Abstract][Full Text] [Related]
9. Methicillin resistant Staphylococcus aureus versus methicillin sensitive Staphylococcus aureus adult haematogenous septic arthritis.
Al-Nammari SS; Bobak P; Venkatesh R
Arch Orthop Trauma Surg; 2007 Sep; 127(7):537-42. PubMed ID: 17260151
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study.
Florescu I; Beuran M; Dimov R; Razbadauskas A; Bochan M; Fichev G; Dukart G; Babinchak T; Cooper CA; Ellis-Grosse EJ; Dartois N; Gandjini H;
J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i17-28. PubMed ID: 18684703
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of daptomycin in complicated skin and skin-structure infections due to methicillin-sensitive and -resistant Staphylococcus aureus: results from the CORE Registry.
Martone WJ; Lamp KC
Curr Med Res Opin; 2006 Dec; 22(12):2337-43. PubMed ID: 17257448
[TBL] [Abstract][Full Text] [Related]
12. Daptomycin versus vancomycin for complicated skin and skin structure infections: clinical and economic outcomes.
Davis SL; McKinnon PS; Hall LM; Delgado G; Rose W; Wilson RF; Rybak MJ
Pharmacotherapy; 2007 Dec; 27(12):1611-8. PubMed ID: 18041881
[TBL] [Abstract][Full Text] [Related]
13. Clinical and economic analysis of methicillin-susceptible and -resistant Staphylococcus aureus infections.
Kopp BJ; Nix DE; Armstrong EP
Ann Pharmacother; 2004 Sep; 38(9):1377-82. PubMed ID: 15266044
[TBL] [Abstract][Full Text] [Related]
14. Analysis of empiric antimicrobial strategies for cellulitis in the era of methicillin-resistant Staphylococcus aureus.
Phillips S; MacDougall C; Holdford DA
Ann Pharmacother; 2007 Jan; 41(1):13-20. PubMed ID: 17200425
[TBL] [Abstract][Full Text] [Related]
15. A prospective investigation of outcomes after hospital discharge for endemic, community-acquired methicillin-resistant and -susceptible Staphylococcus aureus skin infection.
Miller LG; Quan C; Shay A; Mostafaie K; Bharadwa K; Tan N; Matayoshi K; Cronin J; Tan J; Tagudar G; Bayer AS
Clin Infect Dis; 2007 Feb; 44(4):483-92. PubMed ID: 17243049
[TBL] [Abstract][Full Text] [Related]
16. Empiric outpatient therapy with trimethoprim-sulfamethoxazole, cephalexin, or clindamycin for cellulitis.
Khawcharoenporn T; Tice A
Am J Med; 2010 Oct; 123(10):942-50. PubMed ID: 20920697
[TBL] [Abstract][Full Text] [Related]
17. Linezolid for the treatment of methicillin-resistant Staphylococcus aureus infections in children.
Kaplan SL; Afghani B; Lopez P; Wu E; Fleishaker D; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S178-85. PubMed ID: 14520144
[TBL] [Abstract][Full Text] [Related]
18. Clinical trial: comparative effectiveness of cephalexin plus trimethoprim-sulfamethoxazole versus cephalexin alone for treatment of uncomplicated cellulitis: a randomized controlled trial.
Pallin DJ; Binder WD; Allen MB; Lederman M; Parmar S; Filbin MR; Hooper DC; Camargo CA
Clin Infect Dis; 2013 Jun; 56(12):1754-62. PubMed ID: 23457080
[TBL] [Abstract][Full Text] [Related]
19. Pooled analysis of two clinical trials comparing the clinical outcomes of topical ciprofloxacin/dexamethasone otic suspension and polymyxin B/neomycin/hydrocortisone otic suspension for the treatment of acute otitis externa in adults and children.
Rahman A; Rizwan S; Waycaster C; Wall GM
Clin Ther; 2007 Sep; 29(9):1950-6. PubMed ID: 18035194
[TBL] [Abstract][Full Text] [Related]
20. Oral clindamycin 300 mg BID compared with oral amoxicillin/clavulanic acid 1 g BID in the outpatient treatment of acute recurrent pharyngotonsillitis caused by group a beta-hemolytic streptococci: an international, multicenter, randomized, investigator-blinded, prospective trial in patients between the ages of 12 and 60 years.
Mahakit P; Vicente JG; Butt DI; Angeli G; Bansal S; Zambrano D
Clin Ther; 2006 Jan; 28(1):99-109. PubMed ID: 16490583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
